Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 3/20 | 0.44 |
| ▸ | MAOB | P27338 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29731425 | 1.00 | NPC1 (0.51) | NPC1RAB9AMAPTCYP1A2CYP3A4 | |
| SCHEMBL8091142 | 0.90 | MAPT (0.56) | NPC1RAB9AMAPTCYP1A2CYP3A4 | |
| SCHEMBL28934062 | 0.87 | GPR3 (0.45) | NPC1RAB9AMAPTCYP1A2CYP3A4 | |
| SCHEMBL3416670 | 0.82 | NPC1 (0.49) | NPC1RAB9AMAPTCYP1A2CYP3A4 | |
| SCHEMBL9127401 | 0.81 | KDM4E (0.49) | NPC1RAB9AMAPTCYP1A2CYP3A4 | |
| SCHEMBL2789108 | 0.81 | NPC1 (0.70) | NPC1RAB9AMAPTCYP1A2CYP3A4 | |
| SCHEMBL30925001 | 0.81 | NPC1 (0.70) | NPC1RAB9AMAPTCYP1A2CYP3A4 | |
| SCHEMBL9128843 | 0.80 | MAPT (0.55) | NPC1RAB9AMAPTCYP1A2CYP3A4 | |
| SCHEMBL7098554 | 0.80 | MAPT (0.50) | NPC1RAB9AMAPTCYP1A2CYP3A4 | |
| SCHEMBL6688700 | 0.78 | NPC1 (0.51) | NPC1RAB9AMAPTCYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| CN-107652222-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2021-09-10 | — | — | CN | claimed |
| US-10919909-B2 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2021-02-16 | — | — | US | claimed |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | LINTFIELD LIMITED (GB) | 2019-07-11 | — | — | US | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-3415141-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | Icure Pharmaceutical Inc. (KR) | 2018-12-19 | — | — | EP | claimed |
| US-12637600-B2 | Photocurable composition, cured product of same, photofusible resin composition and adhesive set | RESONAC CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| US-20260132243-A1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | RESONAC CORP (JP) | 2026-05-14 | — | — | US | disclosed |
| EP-4555025-B1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM GROUP B V (NL) | 2026-05-13 | — | — | EP | disclosed |
| EP-3902878-B1 | PHOTOINITIATORS | IGM RESINS ITALIA SRL (IT) | 2026-05-06 | — | — | EP | disclosed |
| EP-4410859-B1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTO-MELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | RESONAC CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-4534614-B1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM GROUP B V (NL) | 2026-04-15 | — | — | EP | disclosed |
| EP-4722303-A1 | PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS | IGM Group B.V. (NL) | 2026-04-08 | — | — | EP | disclosed |
| WO-2001058971-A2 | PROCESS FOR THE PRODUCTION OF STRONGLY ADHERENT SURFACE-COATINGS BY PLASMA-ACTIVATED GRAFTING | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-08-16 | — | — | WO | disclosed |
| US-20010012596-A1 | For resist applications; thermostability, storage stability | CIBA SPECIALTY CHEMICALS CORP. | 2001-08-09 | — | — | US | disclosed |
| WO-2001042313-A1 | ADDITIVE COMPOSITION FOR INCREASING THE STORAGE STABILITY OF ETHYLENICALLY UNSATURATED RESINS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-06-14 | — | — | WO | disclosed |
| EP-1095313-A1 | PHOTOPOLYMERIZABLE THERMOSETTING RESIN COMPOSITIONS | Ciba SC Holding AG (CH) | 2001-05-02 | — | — | EP | disclosed |
| WO-2000052530-A1 | OXIME DERIVATIVES AND THE USE THEREOF AS PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000024527-A1 | METHOD FOR PRODUCING ADHESIVE SURFACE COATINGS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-05-04 | — | — | WO | disclosed |
| WO-2000000869-A1 | PHOTOPOLYMERIZABLE THERMOSETTING RESIN COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637600-B2 | Photocurable composition, cured product of same, photofusible resin composition and adhesive set | ESD, CDH1, ASH2L | NPC1 4105/4885RAB9A 4022/4885MAPT 2260/4885 |
| US-10919909-B2 | Photoinitiated reactions | KMO, DECR1, PPOX | NPC1 2000/4885RAB9A 3269/4885MAPT 1604/4885 |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | DOHH, PAH, DBH | NPC1 2594/4885RAB9A 4138/4885MAPT 1061/4885 |
| US-20260132243-A1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | RER1, OXTR, MAP1LC3A | NPC1 4792/4885RAB9A 3549/4885MAPT 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.